DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 205 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $483,722 | +15.1% | 32,751 | +0.8% | 0.00% | 0.0% |
Q2 2023 | $420,129 | +153.4% | 32,504 | +92.3% | 0.00% | – |
Q1 2023 | $165,807 | -18.4% | 16,902 | -11.8% | 0.00% | – |
Q4 2022 | $203,160 | -8.5% | 19,162 | -9.8% | 0.00% | -100.0% |
Q3 2022 | $222,000 | +26.9% | 21,237 | +53.9% | 0.00% | – |
Q2 2022 | $175,000 | +49.6% | 13,803 | +27.9% | 0.00% | – |
Q1 2022 | $117,000 | -26.4% | 10,791 | -4.8% | 0.00% | – |
Q4 2021 | $159,000 | -83.4% | 11,340 | -77.3% | 0.00% | -100.0% |
Q3 2021 | $958,000 | +194.8% | 50,044 | +51.3% | 0.00% | +100.0% |
Q2 2021 | $325,000 | +59.3% | 33,080 | +59.0% | 0.00% | – |
Q1 2021 | $204,000 | +973.7% | 20,811 | +389.7% | 0.00% | – |
Q4 2020 | $19,000 | 0.0% | 4,250 | -5.7% | 0.00% | – |
Q3 2020 | $19,000 | -68.9% | 4,505 | -36.0% | 0.00% | – |
Q2 2020 | $61,000 | +165.2% | 7,041 | +7.6% | 0.00% | – |
Q1 2020 | $23,000 | – | 6,541 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |